COF1_HUMAN - dbPTM
COF1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID COF1_HUMAN
UniProt AC P23528
Protein Name Cofilin-1
Gene Name CFL1
Organism Homo sapiens (Human).
Sequence Length 166
Subcellular Localization Nucleus matrix . Cytoplasm, cytoskeleton . Cell projection, ruffle membrane
Peripheral membrane protein
Cytoplasmic side . Cell projection, lamellipodium membrane
Peripheral membrane protein
Cytoplasmic side . Cell projection, lamellipodium . Note
Protein Description Binds to F-actin and exhibits pH-sensitive F-actin depolymerizing activity. Regulates actin cytoskeleton dynamics. Important for normal progress through mitosis and normal cytokinesis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required for the up-regulation of atypical chemokine receptor ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. [PubMed: 11812157]
Protein Sequence MASGVAVSDGVIKVFNDMKVRKSSTPEEVKKRKKAVLFCLSEDKKNIILEEGKEILVGDVGQTVDDPYATFVKMLPDKDCRYALYDATYETKESKKEDLVFIFWAPESAPLKSKMIYASSKDAIKKKLTGIKHELQANCYEEVKDRCTLAEKLGGSAVISLEGKPL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MASGVAVSD
------CCCCEEECC
18.2620068231
3Phosphorylation-----MASGVAVSDG
-----CCCCEEECCC
32.2829255136
8O-linked_GlycosylationMASGVAVSDGVIKVF
CCCCEEECCCEEEEE
20.9323301498
8PhosphorylationMASGVAVSDGVIKVF
CCCCEEECCCEEEEE
20.9330266825
13SumoylationAVSDGVIKVFNDMKV
EECCCEEEEECCCCC
38.07-
13AcetylationAVSDGVIKVFNDMKV
EECCCEEEEECCCCC
38.0719608861
13SumoylationAVSDGVIKVFNDMKV
EECCCEEEEECCCCC
38.0719608861
13UbiquitinationAVSDGVIKVFNDMKV
EECCCEEEEECCCCC
38.0721890473
19SumoylationIKVFNDMKVRKSSTP
EEEECCCCCCCCCCH
41.57-
192-HydroxyisobutyrylationIKVFNDMKVRKSSTP
EEEECCCCCCCCCCH
41.57-
19AcetylationIKVFNDMKVRKSSTP
EEEECCCCCCCCCCH
41.5725825284
19MalonylationIKVFNDMKVRKSSTP
EEEECCCCCCCCCCH
41.5726320211
19MethylationIKVFNDMKVRKSSTP
EEEECCCCCCCCCCH
41.5719608861
19SumoylationIKVFNDMKVRKSSTP
EEEECCCCCCCCCCH
41.5719608861
19UbiquitinationIKVFNDMKVRKSSTP
EEEECCCCCCCCCCH
41.5721890473
22AcetylationFNDMKVRKSSTPEEV
ECCCCCCCCCCHHHH
52.3127178108
22UbiquitinationFNDMKVRKSSTPEEV
ECCCCCCCCCCHHHH
52.31-
23PhosphorylationNDMKVRKSSTPEEVK
CCCCCCCCCCHHHHH
28.9630278072
24PhosphorylationDMKVRKSSTPEEVKK
CCCCCCCCCHHHHHH
51.5229255136
25PhosphorylationMKVRKSSTPEEVKKR
CCCCCCCCHHHHHHH
41.6429255136
30SumoylationSSTPEEVKKRKKAVL
CCCHHHHHHHHCEEE
50.57-
302-HydroxyisobutyrylationSSTPEEVKKRKKAVL
CCCHHHHHHHHCEEE
50.57-
30AcetylationSSTPEEVKKRKKAVL
CCCHHHHHHHHCEEE
50.5721339330
30SumoylationSSTPEEVKKRKKAVL
CCCHHHHHHHHCEEE
50.57-
30UbiquitinationSSTPEEVKKRKKAVL
CCCHHHHHHHHCEEE
50.57-
31AcetylationSTPEEVKKRKKAVLF
CCHHHHHHHHCEEEE
74.7111923949
33AcetylationPEEVKKRKKAVLFCL
HHHHHHHHCEEEEEC
54.707616599
33UbiquitinationPEEVKKRKKAVLFCL
HHHHHHHHCEEEEEC
54.70-
34SumoylationEEVKKRKKAVLFCLS
HHHHHHHCEEEEECC
48.00-
342-HydroxyisobutyrylationEEVKKRKKAVLFCLS
HHHHHHHCEEEEECC
48.00-
34AcetylationEEVKKRKKAVLFCLS
HHHHHHHCEEEEECC
48.0026051181
34SumoylationEEVKKRKKAVLFCLS
HHHHHHHCEEEEECC
48.00-
34UbiquitinationEEVKKRKKAVLFCLS
HHHHHHHCEEEEECC
48.00-
39GlutathionylationRKKAVLFCLSEDKKN
HHCEEEEECCCCCCE
3.4122555962
39S-nitrosylationRKKAVLFCLSEDKKN
HHCEEEEECCCCCCE
3.4124105792
39S-palmitoylationRKKAVLFCLSEDKKN
HHCEEEEECCCCCCE
3.4129575903
41PhosphorylationKAVLFCLSEDKKNII
CEEEEECCCCCCEEE
44.9523401153
44SumoylationLFCLSEDKKNIILEE
EEECCCCCCEEEECC
43.60-
44AcetylationLFCLSEDKKNIILEE
EEECCCCCCEEEECC
43.6023954790
44MalonylationLFCLSEDKKNIILEE
EEECCCCCCEEEECC
43.6026320211
44SumoylationLFCLSEDKKNIILEE
EEECCCCCCEEEECC
43.60-
44UbiquitinationLFCLSEDKKNIILEE
EEECCCCCCEEEECC
43.60-
45SumoylationFCLSEDKKNIILEEG
EECCCCCCEEEECCC
66.74-
45AcetylationFCLSEDKKNIILEEG
EECCCCCCEEEECCC
66.7427452117
45MalonylationFCLSEDKKNIILEEG
EECCCCCCEEEECCC
66.7426320211
45SumoylationFCLSEDKKNIILEEG
EECCCCCCEEEECCC
66.74-
45UbiquitinationFCLSEDKKNIILEEG
EECCCCCCEEEECCC
66.74-
53SumoylationNIILEEGKEILVGDV
EEEECCCCEEEECCC
44.88-
53AcetylationNIILEEGKEILVGDV
EEEECCCCEEEECCC
44.8826822725
53SumoylationNIILEEGKEILVGDV
EEEECCCCEEEECCC
44.88-
53UbiquitinationNIILEEGKEILVGDV
EEEECCCCEEEECCC
44.8821906983
63PhosphorylationLVGDVGQTVDDPYAT
EECCCCCCCCCCHHH
21.7028450419
68NitrationGQTVDDPYATFVKML
CCCCCCCHHHHHCCC
25.85-
68PhosphorylationGQTVDDPYATFVKML
CCCCCCCHHHHHCCC
25.8527273156
70PhosphorylationTVDDPYATFVKMLPD
CCCCCHHHHHCCCCC
24.1025159151
73AcetylationDPYATFVKMLPDKDC
CCHHHHHCCCCCCCC
30.4519608861
73SumoylationDPYATFVKMLPDKDC
CCHHHHHCCCCCCCC
30.4519608861
73UbiquitinationDPYATFVKMLPDKDC
CCHHHHHCCCCCCCC
30.4573
74SulfoxidationPYATFVKMLPDKDCR
CHHHHHCCCCCCCCC
5.7330846556
78AcetylationFVKMLPDKDCRYALY
HHCCCCCCCCCHHEE
57.7123749302
78MalonylationFVKMLPDKDCRYALY
HHCCCCCCCCCHHEE
57.7126320211
78UbiquitinationFVKMLPDKDCRYALY
HHCCCCCCCCCHHEE
57.71-
80GlutathionylationKMLPDKDCRYALYDA
CCCCCCCCCHHEEEC
4.4022555962
80S-nitrosylationKMLPDKDCRYALYDA
CCCCCCCCCHHEEEC
4.4024105792
82PhosphorylationLPDKDCRYALYDATY
CCCCCCCHHEEECCC
13.8030550596
85PhosphorylationKDCRYALYDATYETK
CCCCHHEEECCCCCC
8.7227273156
88PhosphorylationRYALYDATYETKESK
CHHEEECCCCCCCCC
20.9927273156
89PhosphorylationYALYDATYETKESKK
HHEEECCCCCCCCCC
24.2625159151
91PhosphorylationLYDATYETKESKKED
EEECCCCCCCCCCCC
29.6927273156
922-HydroxyisobutyrylationYDATYETKESKKEDL
EECCCCCCCCCCCCE
48.31-
92AcetylationYDATYETKESKKEDL
EECCCCCCCCCCCCE
48.3123954790
92MalonylationYDATYETKESKKEDL
EECCCCCCCCCCCCE
48.3126320211
92UbiquitinationYDATYETKESKKEDL
EECCCCCCCCCCCCE
48.3119608861
94PhosphorylationATYETKESKKEDLVF
CCCCCCCCCCCCEEE
51.0526356563
95UbiquitinationTYETKESKKEDLVFI
CCCCCCCCCCCEEEE
62.36-
96TrimethylationYETKESKKEDLVFIF
CCCCCCCCCCEEEEE
66.78-
962-HydroxyisobutyrylationYETKESKKEDLVFIF
CCCCCCCCCCEEEEE
66.78-
96AcetylationYETKESKKEDLVFIF
CCCCCCCCCCEEEEE
66.78129419
96MethylationYETKESKKEDLVFIF
CCCCCCCCCCEEEEE
66.78-
96UbiquitinationYETKESKKEDLVFIF
CCCCCCCCCCEEEEE
66.7821890473
108O-linked_GlycosylationFIFWAPESAPLKSKM
EEEECCCCCCCCCCE
33.8423301498
108PhosphorylationFIFWAPESAPLKSKM
EEEECCCCCCCCCCE
33.8428450419
112SumoylationAPESAPLKSKMIYAS
CCCCCCCCCCEEEEC
47.15-
1122-HydroxyisobutyrylationAPESAPLKSKMIYAS
CCCCCCCCCCEEEEC
47.15-
112AcetylationAPESAPLKSKMIYAS
CCCCCCCCCCEEEEC
47.1525953088
112SumoylationAPESAPLKSKMIYAS
CCCCCCCCCCEEEEC
47.15-
112UbiquitinationAPESAPLKSKMIYAS
CCCCCCCCCCEEEEC
47.1521906983
113PhosphorylationPESAPLKSKMIYASS
CCCCCCCCCEEEECC
34.8328270605
114SumoylationESAPLKSKMIYASSK
CCCCCCCCEEEECCH
27.94-
1142-HydroxyisobutyrylationESAPLKSKMIYASSK
CCCCCCCCEEEECCH
27.94-
114AcetylationESAPLKSKMIYASSK
CCCCCCCCEEEECCH
27.9419608861
114MethylationESAPLKSKMIYASSK
CCCCCCCCEEEECCH
27.9424129315
114SuccinylationESAPLKSKMIYASSK
CCCCCCCCEEEECCH
27.9423954790
114SumoylationESAPLKSKMIYASSK
CCCCCCCCEEEECCH
27.9419608861
114UbiquitinationESAPLKSKMIYASSK
CCCCCCCCEEEECCH
27.9421890473
115SulfoxidationSAPLKSKMIYASSKD
CCCCCCCEEEECCHH
3.5025058340
117PhosphorylationPLKSKMIYASSKDAI
CCCCCEEEECCHHHH
9.2727273156
119PhosphorylationKSKMIYASSKDAIKK
CCCEEEECCHHHHHH
22.4326356563
120PhosphorylationSKMIYASSKDAIKKK
CCEEEECCHHHHHHH
26.7826356563
121SumoylationKMIYASSKDAIKKKL
CEEEECCHHHHHHHH
49.00-
121AcetylationKMIYASSKDAIKKKL
CEEEECCHHHHHHHH
49.0023954790
121MalonylationKMIYASSKDAIKKKL
CEEEECCHHHHHHHH
49.0026320211
121SumoylationKMIYASSKDAIKKKL
CEEEECCHHHHHHHH
49.0019608861
121UbiquitinationKMIYASSKDAIKKKL
CEEEECCHHHHHHHH
49.0019608861
125AcetylationASSKDAIKKKLTGIK
ECCHHHHHHHHHCCC
45.648273235
126AcetylationSSKDAIKKKLTGIKH
CCHHHHHHHHHCCCH
47.0770231
127AcetylationSKDAIKKKLTGIKHE
CHHHHHHHHHCCCHH
46.4070235
127UbiquitinationSKDAIKKKLTGIKHE
CHHHHHHHHHCCCHH
46.4021890473
129PhosphorylationDAIKKKLTGIKHELQ
HHHHHHHHCCCHHHH
45.8229496963
132SumoylationKKKLTGIKHELQANC
HHHHHCCCHHHHHCH
32.16-
1322-HydroxyisobutyrylationKKKLTGIKHELQANC
HHHHHCCCHHHHHCH
32.16-
132AcetylationKKKLTGIKHELQANC
HHHHHCCCHHHHHCH
32.1616916647
132MalonylationKKKLTGIKHELQANC
HHHHHCCCHHHHHCH
32.1626320211
132SumoylationKKKLTGIKHELQANC
HHHHHCCCHHHHHCH
32.1628112733
132UbiquitinationKKKLTGIKHELQANC
HHHHHCCCHHHHHCH
32.16-
139S-nitrosocysteineKHELQANCYEEVKDR
CHHHHHCHHHHHHHH
5.19-
139GlutathionylationKHELQANCYEEVKDR
CHHHHHCHHHHHHHH
5.1922555962
139S-nitrosylationKHELQANCYEEVKDR
CHHHHHCHHHHHHHH
5.1924105792
140NitrationHELQANCYEEVKDRC
HHHHHCHHHHHHHHC
18.22-
140PhosphorylationHELQANCYEEVKDRC
HHHHHCHHHHHHHHC
18.2225159151
1442-HydroxyisobutyrylationANCYEEVKDRCTLAE
HCHHHHHHHHCHHHH
42.61-
144AcetylationANCYEEVKDRCTLAE
HCHHHHHHHHCHHHH
42.6119608861
144MalonylationANCYEEVKDRCTLAE
HCHHHHHHHHCHHHH
42.6126320211
144UbiquitinationANCYEEVKDRCTLAE
HCHHHHHHHHCHHHH
42.6119608861
147S-nitrosocysteineYEEVKDRCTLAEKLG
HHHHHHHCHHHHHHC
5.40-
147S-nitrosylationYEEVKDRCTLAEKLG
HHHHHHHCHHHHHHC
5.4019483679
148PhosphorylationEEVKDRCTLAEKLGG
HHHHHHCHHHHHHCC
29.8720068231
152AcetylationDRCTLAEKLGGSAVI
HHCHHHHHHCCCEEE
46.9925953088
152UbiquitinationDRCTLAEKLGGSAVI
HHCHHHHHHCCCEEE
46.99-
156PhosphorylationLAEKLGGSAVISLEG
HHHHHCCCEEEEECC
19.9829255136
160PhosphorylationLGGSAVISLEGKPL-
HCCCEEEEECCEEC-
17.4830266825
164SumoylationAVISLEGKPL-----
EEEEECCEEC-----
33.50-
164AcetylationAVISLEGKPL-----
EEEEECCEEC-----
33.5025953088
164SumoylationAVISLEGKPL-----
EEEEECCEEC-----
33.50-
164UbiquitinationAVISLEGKPL-----
EEEEECCEEC-----
33.5021906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
3SPhosphorylationKinasePRKD1Q15139
PSP
3SPhosphorylationKinaseLIMK1P53667
PSP
3SPhosphorylationKinaseLIMK1P53669
PSP
3SPhosphorylationKinaseLIMK2P53671
PSP
3SPhosphorylationKinaseNRKQ7Z2Y5
Uniprot
3SPhosphorylationKinaseROCK2P70336
PSP
3SPhosphorylationKinaseTESK1Q15569
PSP
3SPhosphorylationKinaseTESK1Q63572
PSP
3SPhosphorylationKinaseTESK2Q96S53
PhosphoELM
23SPhosphorylationKinasePRKCAP17252
GPS
24SPhosphorylationKinasePRKCAP17252
GPS
68YPhosphorylationKinaseSRCP12931
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
3SPhosphorylation

12837278
3SPhosphorylation

12837278
24SPhosphorylation

23633677

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of COF1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TAGL_HUMANTAGLNphysical
17353931
CAP1_HUMANCAP1physical
11950878
ACTS_HUMANACTA1physical
11950878
ROCK1_HUMANROCK1physical
10436159
LIMK2_HUMANLIMK2physical
10436159
TPIS_HUMANTPI1physical
12359716
RPAC1_HUMANPOLR1Cphysical
22939629
RL40_HUMANUBA52physical
22939629
ARRB1_HUMANARRB1physical
17500066
ARRB2_HUMANARRB2physical
17500066
MTAP_HUMANMTAPphysical
22863883
SGT1_HUMANSUGT1physical
22863883
COF2_HUMANCFL2physical
25416956
CAP1_HUMANCAP1physical
26186194
CAP2_HUMANCAP2physical
26186194
GABT_HUMANABATphysical
26344197
THIM_HUMANACAA2physical
26344197
AK1A1_HUMANAKR1A1physical
26344197
AL4A1_HUMANALDH4A1physical
26344197
ALDOA_HUMANALDOAphysical
26344197
ARF4_HUMANARF4physical
26344197
CATA_HUMANCATphysical
26344197
COX17_HUMANCOX17physical
26344197
CSRP1_HUMANCSRP1physical
26344197
DBNL_HUMANDBNLphysical
26344197
DUT_HUMANDUTphysical
26344197
ENOA_HUMANENO1physical
26344197
FAHD1_HUMANFAHD1physical
26344197
G3P_HUMANGAPDHphysical
26344197
HDHD1_HUMANHDHD1physical
26344197
JUPI1_HUMANHN1physical
26344197
CH10_HUMANHSPE1physical
26344197
LDHA_HUMANLDHAphysical
26344197
LDH6A_HUMANLDHAL6Aphysical
26344197
LDHB_HUMANLDHBphysical
26344197
LYPA2_HUMANLYPLA2physical
26344197
MDHM_HUMANMDH2physical
26344197
NDKA_HUMANNME1physical
26344197
NDKB_HUMANNME2physical
26344197
PEBP1_HUMANPEBP1physical
26344197
PIN1_HUMANPIN1physical
26344197
KPYM_HUMANPKMphysical
26344197
PPIA_HUMANPPIAphysical
26344197
PRDX1_HUMANPRDX1physical
26344197
PRDX5_HUMANPRDX5physical
26344197
RTN4_HUMANRTN4physical
26344197
TAGL2_HUMANTAGLN2physical
26344197
TNG2_HUMANTANGO2physical
26344197
TKT_HUMANTKTphysical
26344197
TRAP1_HUMANTRAP1physical
26344197
UFD1_HUMANUFD1Lphysical
26344197
UFM1_HUMANUFM1physical
26344197
COF2_HUMANCFL2physical
21516116
CAP2_HUMANCAP2physical
28514442
CAP1_HUMANCAP1physical
28514442
ACTBL_HUMANACTBL2physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of COF1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-3, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13; LYS-19; LYS-73 ANDLYS-144, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-132, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; TYR-68 AND SER-156,AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-3, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-41 AND SER-156,AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND THR-25, AND MASSSPECTROMETRY.
"Cofilin phosphorylation and actin polymerization by NRK/NESK, amember of the germinal center kinase family.";
Nakano K., Kanai-Azuma M., Kanai Y., Moriyama K., Yazaki K.,Hayashi Y., Kitamura N.;
Exp. Cell Res. 287:219-227(2003).
Cited for: PHOSPHORYLATION AT SER-3 BY NRK.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-89 AND TYR-140, AND MASSSPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-140, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-140, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-140, AND MASSSPECTROMETRY.

TOP